Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Drug-Drug Interaction between DW4421 and Amoxicillin/Clarithromycin
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sequence 1 | Experimental | A-B-C (A: DW4421 1T bid; B: DW4421-1 2C bid + DW4421-2 1T bid; C: DW4421 1T bid + DW4421-1 2C bid + DW4421-2 1T bid) |
|
| Sequence 2 | Experimental | A-C-B (A: DW4421 1T bid; B: DW4421-1 2C bid + DW4421-2 1T bid; C: DW4421 1T bid + DW4421-1 2C bid + DW4421-2 1T bid) |
|
| Sequence 3 | Experimental | B-A-B (A: DW4421 1T bid; B: DW4421-1 2C bid + DW4421-2 1T bid; C: DW4421 1T bid + DW4421-1 2C bid + DW4421-2 1T bid) |
|
| Sequence 4 | Experimental | B-C-A (A: DW4421 1T bid; B: DW4421-1 2C bid + DW4421-2 1T bid; C: DW4421 1T bid + DW4421-1 2C bid + DW4421-2 1T bid) |
|
| Sequence 5 | Experimental | C-A-B (A: DW4421 1T bid; B: DW4421-1 2C bid + DW4421-2 1T bid; C: DW4421 1T bid + DW4421-1 2C bid + DW4421-2 1T bid) |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| DW4421 | Drug | 1 tablet will be orally administered |
|
| Measure | Description | Time Frame |
|---|---|---|
| Cmax,ss: Maximum concentration of DW4421, DW4421-1 and DW4421-2 at steady state | Up to day 6 or day 7 | |
| AUCÏ„,ss: Area under the drug concentration-time curve of DW4421, DW4421-1, DW4421-2 within a dosing interval at steady state | Up to day 6 or day 7 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chungbuk National University Hospital | Cheongju-si | North Chungcheong | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Sequence 6 | Experimental | C-B-A (A: DW4421 1T bid; B: DW4421-1 2C bid + DW4421-2 1T bid; C: DW4421 1T bid + DW4421-1 2C bid + DW4421-2 1T bid) |
|
| DW4421-1 | Drug | 2 capsules will be orally administered |
|
| DW4421-2 | Drug | 1 tablet will be orally administered |
|